Novartis receives approval for a potential blockbuster psoriasis treatment. Read More
Analyst Articles
This company squeezes the most from basic services. Read More
Continued economic growth in the U.S. and U.K. bodes well for this international utility. Read More
Hong Kong protests offer investors an opportunity to pick up a British global financial leader at a discount Read More
Several MLPs are counting on acquisitions to drive growth, while Kinder Morgan has seen a big increase in short interest ahead of its merger. Read More
After a rough July investors took some earnings disappointments in stride, continuing to focus on the rising distributions. Read More
MLP Profits has upgraded Kinder Morgan Energy Partners (NYSE: KMP) to a Buy, downgraded Crestwood Midstream Partners (NYSE: CMLP) to a Sell and raised buy limits on numerous portfolio recommendations. Read More
We're upgrading Kinder Morgan Energy Partners to a buy and lifting the target on Oiltanking above the current price alongside many other limit raises in the wake of the strong first-half rally. But Crestwood Midstream is a sell after betting the farm. Read More
Numerous portfolio recommendations notched record highs at the forefront of the energy rally. But only one earned a quick raise beyond a price target set two months earlier. Read More